Literature for Z-FA-FMK

Summary Literature

(Topics flags: I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

    2019
  1. Wang,Y., Xu,C., Ma,L., Mou,Y., Zhang,B., Zhou,S., Tian,Y., Trinh,J., Zhang,X. and Li,X.J.
    Drug screening with human SMN2 reporter identifies SMN protein stabilizers to correct SMA pathology
    Life Sci Alliance2, PubMed  Europe PubMed DOI  I
  2. 2015
  3. Ferrao,P.M., D'Avila-Levy,C.M., Araujo-Jorge,T.C., Degrave,W.M., Goncalves,A.S., Garzoni,L.R., Lima,A.P., Feige,J.J., Bailly,S., Mendonca-Lima,L. and Waghabi,M.C.
    Cruzipain activates latent TGF-beta from host cells during T. cruzi invasion
    PLoS ONE10, e0124832- PubMed  Europe PubMed DOI  I
  4. 2002
  5. [YEAR:26-4-2002]Guo,M., Mathieu,P.A., Linebaugh,B., Sloane,B.F. and Reiners,J.J., Jr.
    Phorbol ester activation of a proteolytic cascade capable of activating latent transforming growth factor-beta - a process initiated by the exocytosis of cathepsin B
    J Biol Chem277, 14829-14837. PubMed  Europe PubMed DOI  I
  6. 1985
  7. Rasnick,D.
    Synthesis of peptide fluoromethyl ketones and the inhibition of human cathepsin B
    Anal Biochem149, 461-465. PubMed  Europe PubMed  I